Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT04868799
Finding New Targets by Proteomic Approaches (InnovRT1)
Sponsor: Assistance Publique - Hôpitaux de Paris
View on ClinicalTrials.gov
Summary
The investigators aim to explore the inter tumor heterogeneity by a proteomic approach of a wide series of rhabdoid tumors, from both intra and extra cranial origins.
Official title: Heterogeneity in Rhabdoid Tumors : Proteomic and Single-Cell Analyses to Identify New Therapeutic Targets
Key Details
Gender
All
Age Range
Any - 17 Years
Study Type
OBSERVATIONAL
Enrollment
44
Start Date
2022-08-12
Completion Date
2023-02-17
Last Updated
2026-09-24
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
Mass spectrometry
Characterization of the proteomic and phosphoproteomic landscape using mass spectrometry
Locations (1)
Service de neurochirurgie - Hôpital Necker Enfants malades
Paris, France